Dimensional Fund Advisors LP Grows Stock Holdings in Maximus, Inc. $MMS

Key Points

• Dimensional Fund Advisors LP increased its stake in Maximus, Inc. by 20.5% during the first quarter, holding 1,695,582 shares valued at approximately $115.6 million.
• Maximus reported earnings of $2.16 per share for the last quarter, exceeding analyst expectations and showing a 2.5% increase in revenue year-over-year.
• The company announced a $0.30 quarterly dividend to be paid on August 31st, with an annualized yield of 1.4%.

Dimensional Fund Advisors LP increased its position in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 20.5% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,695,582 shares of the health services provider's stock after purchasing an additional 288,990 shares during the period. Dimensional Fund Advisors LP owned approximately 3.00% of Maximus worth $115,620,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in MMS. SG Capital Management LLC purchased a new position in shares of Maximus during the 4th quarter worth about $30,285,000. Reinhart Partners LLC. boosted its position in Maximus by 65.4% in the 1st quarter. Reinhart Partners LLC. now owns 911,511 shares of the health services provider's stock valued at $62,156,000 after buying an additional 360,365 shares during the period. Boston Partners purchased a new stake in Maximus in the 1st quarter valued at about $20,983,000. Squarepoint Ops LLC purchased a new stake in Maximus in the 4th quarter valued at about $22,661,000. Finally, Voloridge Investment Management LLC boosted its position in Maximus by 306.8% in the 4th quarter. Voloridge Investment Management LLC now owns 376,055 shares of the health services provider's stock valued at $28,073,000 after buying an additional 283,608 shares during the period. 97.21% of the stock is owned by hedge funds and other institutional investors.

Maximus Stock Up 0.1%

Shares of NYSE MMS traded up $0.10 during trading hours on Thursday, hitting $87.66. 552,291 shares of the stock were exchanged, compared to its average volume of 699,551. The company has a quick ratio of 2.27, a current ratio of 2.27 and a debt-to-equity ratio of 0.91. The company has a market cap of $4.94 billion, a PE ratio of 16.14 and a beta of 0.60. The firm has a fifty day moving average price of $75.92 and a 200-day moving average price of $71.50. Maximus, Inc. has a 12 month low of $63.77 and a 12 month high of $93.94.

Maximus (NYSE:MMS - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The health services provider reported $2.16 EPS for the quarter, topping the consensus estimate of $1.39 by $0.77. The firm had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.29 billion. Maximus had a net margin of 5.83% and a return on equity of 24.44%. Maximus's revenue was up 2.5% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.74 EPS. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. On average, sell-side analysts expect that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Sunday, August 31st. Shareholders of record on Friday, August 15th will be paid a dividend of $0.30 per share. The ex-dividend date is Friday, August 15th. This represents a $1.20 dividend on an annualized basis and a yield of 1.4%. Maximus's dividend payout ratio is presently 22.10%.

Insider Transactions at Maximus

In other Maximus news, Director Gayathri Rajan sold 7,913 shares of the company's stock in a transaction that occurred on Friday, May 30th. The shares were sold at an average price of $72.38, for a total transaction of $572,742.94. Following the transaction, the director owned 14,205 shares in the company, valued at approximately $1,028,157.90. This represents a 35.78% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 1.60% of the company's stock.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on MMS shares. Zacks Research raised shares of Maximus from a "hold" rating to a "strong-buy" rating in a research report on Tuesday. Wall Street Zen cut shares of Maximus from a "buy" rating to a "hold" rating in a research report on Thursday, May 15th. One investment analyst has rated the stock with a Strong Buy rating and one has issued a Buy rating to the company's stock. Based on data from MarketBeat.com, Maximus currently has a consensus rating of "Strong Buy" and an average price target of $90.00.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.